Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Myelodysplastic Syndromes 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Hematologic Neoplasms 18Hodgkin Disease 17Lymphoma, Non-Hodgkin 16Myeloproliferative Disorders 14Leukemia, Lymphocytic, Chronic, B-Cell 13Leukemia, Biphenotypic, Acute 13Leukemia 13Graft vs Host Disease 13Leukemia, Myelomonocytic, Chronic 11Anemia, Refractory, with Excess of Blasts 11Multiple Myeloma 10Lymphoma 10Primary Myelofibrosis 9Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Prolymphocytic 6Waldenstrom Macroglobulinemia 5Lymphoma, Large B-Cell, Diffuse 5Hematologic Diseases 5Burkitt Lymphoma 5Anemia, Aplastic 5Polycythemia Vera 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid 4Blast Crisis 4

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Glioblastoma × Mycophenolic Acid × 1 year × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡